nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—HTR2B—hypertension	0.229	0.472	CbGaD
Minaprine—SLC6A4—hypertension	0.0927	0.191	CbGaD
Minaprine—DRD2—hypertension	0.0922	0.19	CbGaD
Minaprine—HTR2A—hypertension	0.0712	0.147	CbGaD
Minaprine—DRD1—Fenoldopam—hypertension	0.0545	0.16	CbGbCtD
Minaprine—DRD2—Fenoldopam—hypertension	0.0331	0.0974	CbGbCtD
Minaprine—CHRM1—Nicardipine—hypertension	0.0233	0.0684	CbGbCtD
Minaprine—SLC6A4—Verapamil—hypertension	0.0197	0.0579	CbGbCtD
Minaprine—CYP2D6—Labetalol—hypertension	0.0165	0.0486	CbGbCtD
Minaprine—CYP2D6—Nebivolol—hypertension	0.0165	0.0486	CbGbCtD
Minaprine—CYP2D6—Acebutolol—hypertension	0.0151	0.0445	CbGbCtD
Minaprine—CYP2D6—Metoprolol—hypertension	0.0141	0.0414	CbGbCtD
Minaprine—CYP2D6—Pindolol—hypertension	0.0141	0.0414	CbGbCtD
Minaprine—CYP2D6—Betaxolol—hypertension	0.0125	0.0369	CbGbCtD
Minaprine—CYP2D6—Doxazosin—hypertension	0.011	0.0325	CbGbCtD
Minaprine—CYP2D6—Diltiazem—hypertension	0.0107	0.0313	CbGbCtD
Minaprine—CYP2D6—Bepridil—hypertension	0.00949	0.0279	CbGbCtD
Minaprine—CYP2D6—Irbesartan—hypertension	0.00868	0.0256	CbGbCtD
Minaprine—CYP2D6—Amlodipine—hypertension	0.00851	0.0251	CbGbCtD
Minaprine—CYP2D6—Felodipine—hypertension	0.00821	0.0242	CbGbCtD
Minaprine—CYP2D6—Timolol—hypertension	0.00807	0.0238	CbGbCtD
Minaprine—CYP2D6—Nifedipine—hypertension	0.00794	0.0234	CbGbCtD
Minaprine—CYP2D6—Nicardipine—hypertension	0.00782	0.023	CbGbCtD
Minaprine—CYP2D6—Carvedilol—hypertension	0.00782	0.023	CbGbCtD
Minaprine—CYP2D6—Propranolol—hypertension	0.00719	0.0212	CbGbCtD
Minaprine—CYP2D6—Captopril—hypertension	0.00711	0.0209	CbGbCtD
Minaprine—CYP2D6—Clonidine—hypertension	0.00686	0.0202	CbGbCtD
Minaprine—CYP2D6—Atorvastatin—hypertension	0.00612	0.018	CbGbCtD
Minaprine—CYP2D6—Verapamil—hypertension	0.00494	0.0145	CbGbCtD
Minaprine—MAOA—locus ceruleus—hypertension	0.00358	0.0856	CbGeAlD
Minaprine—HTR2A—arteriole—hypertension	0.0029	0.0693	CbGeAlD
Minaprine—HTR2A—locus ceruleus—hypertension	0.00234	0.0559	CbGeAlD
Minaprine—HTR2A—pulmonary artery—hypertension	0.0019	0.0454	CbGeAlD
Minaprine—HTR2A—sympathetic nervous system—hypertension	0.00185	0.0442	CbGeAlD
Minaprine—HTR2A—vagus nerve—hypertension	0.00179	0.0428	CbGeAlD
Minaprine—HTR2A—vein—hypertension	0.00173	0.0413	CbGeAlD
Minaprine—HTR2A—autonomic nervous system—hypertension	0.00124	0.0297	CbGeAlD
Minaprine—HTR2A—hindlimb—hypertension	0.00115	0.0275	CbGeAlD
Minaprine—HTR2A—urine—hypertension	0.00101	0.0242	CbGeAlD
Minaprine—CYP2D6—urine—hypertension	0.000923	0.022	CbGeAlD
Minaprine—DRD1—brainstem—hypertension	0.00077	0.0184	CbGeAlD
Minaprine—ACHE—heart—hypertension	0.000726	0.0173	CbGeAlD
Minaprine—HTR2A—artery—hypertension	0.000705	0.0168	CbGeAlD
Minaprine—MAOA—cardiac ventricle—hypertension	0.000606	0.0145	CbGeAlD
Minaprine—HTR2C—brainstem—hypertension	0.000598	0.0143	CbGeAlD
Minaprine—HTR2A—endothelium—hypertension	0.000595	0.0142	CbGeAlD
Minaprine—ACHE—medulla oblongata—hypertension	0.000585	0.014	CbGeAlD
Minaprine—MAOA—myocardium—hypertension	0.00057	0.0136	CbGeAlD
Minaprine—SLC6A4—brainstem—hypertension	0.000567	0.0135	CbGeAlD
Minaprine—HTR2A—blood vessel—hypertension	0.000549	0.0131	CbGeAlD
Minaprine—ACHE—adrenal gland—hypertension	0.000542	0.0129	CbGeAlD
Minaprine—HTR2B—adrenal cortex—hypertension	0.000502	0.012	CbGeAlD
Minaprine—HTR2B—heart—hypertension	0.000486	0.0116	CbGeAlD
Minaprine—HTR2B—smooth muscle tissue—hypertension	0.000482	0.0115	CbGeAlD
Minaprine—HTR2B—decidua—hypertension	0.000473	0.0113	CbGeAlD
Minaprine—CHRM1—cardiovascular system—hypertension	0.000461	0.011	CbGeAlD
Minaprine—MAOA—brainstem—hypertension	0.00046	0.011	CbGeAlD
Minaprine—HTR2B—cardiovascular system—hypertension	0.000459	0.011	CbGeAlD
Minaprine—DRD2—brainstem—hypertension	0.000455	0.0109	CbGeAlD
Minaprine—HTR2B—cortex of kidney—hypertension	0.000437	0.0104	CbGeAlD
Minaprine—MAOA—nephron tubule—hypertension	0.000418	0.00998	CbGeAlD
Minaprine—HTR2C—medulla oblongata—hypertension	0.000417	0.00996	CbGeAlD
Minaprine—MAOA—adrenal cortex—hypertension	0.000411	0.00983	CbGeAlD
Minaprine—MAOA—heart—hypertension	0.000398	0.0095	CbGeAlD
Minaprine—DRD1—central nervous system—hypertension	0.000388	0.00928	CbGeAlD
Minaprine—MAOA—decidua—hypertension	0.000387	0.00924	CbGeAlD
Minaprine—MAOA—cardiovascular system—hypertension	0.000375	0.00897	CbGeAlD
Minaprine—MAOA—kidney—hypertension	0.000367	0.00877	CbGeAlD
Minaprine—HTR2B—adrenal gland—hypertension	0.000363	0.00867	CbGeAlD
Minaprine—MAOA—cortex of kidney—hypertension	0.000358	0.00855	CbGeAlD
Minaprine—Gefitinib—EGFR—hypertension	0.000353	0.366	CrCbGaD
Minaprine—MAOA—cardiac atrium—hypertension	0.00034	0.00813	CbGeAlD
Minaprine—MAOA—medulla oblongata—hypertension	0.000321	0.00766	CbGeAlD
Minaprine—SLC6A4—endocrine gland—hypertension	0.000317	0.00758	CbGeAlD
Minaprine—CHRM1—endocrine gland—hypertension	0.000316	0.00755	CbGeAlD
Minaprine—HTR2C—central nervous system—hypertension	0.000302	0.00721	CbGeAlD
Minaprine—HTR2A—brainstem—hypertension	0.0003	0.00717	CbGeAlD
Minaprine—Gefitinib—CYP3A5—hypertension	0.000297	0.309	CrCbGaD
Minaprine—MAOA—adrenal gland—hypertension	0.000297	0.00709	CbGeAlD
Minaprine—SLC6A4—central nervous system—hypertension	0.000286	0.00683	CbGeAlD
Minaprine—CHRM1—central nervous system—hypertension	0.000285	0.00681	CbGeAlD
Minaprine—HTR2B—central nervous system—hypertension	0.000283	0.00677	CbGeAlD
Minaprine—CYP2D6—brainstem—hypertension	0.000273	0.00653	CbGeAlD
Minaprine—HTR2A—heart—hypertension	0.00026	0.0062	CbGeAlD
Minaprine—MAOA—endocrine gland—hypertension	0.000257	0.00615	CbGeAlD
Minaprine—HTR2A—smooth muscle tissue—hypertension	0.000257	0.00615	CbGeAlD
Minaprine—DRD2—endocrine gland—hypertension	0.000255	0.00608	CbGeAlD
Minaprine—HTR2A—cardiovascular system—hypertension	0.000245	0.00585	CbGeAlD
Minaprine—HTR2A—kidney—hypertension	0.00024	0.00572	CbGeAlD
Minaprine—MAOA—central nervous system—hypertension	0.000232	0.00554	CbGeAlD
Minaprine—DRD2—central nervous system—hypertension	0.000229	0.00548	CbGeAlD
Minaprine—CYP2D6—kidney—hypertension	0.000218	0.00521	CbGeAlD
Minaprine—HTR2A—medulla oblongata—hypertension	0.000209	0.005	CbGeAlD
Minaprine—Gefitinib—CYP1A1—hypertension	0.000202	0.209	CrCbGaD
Minaprine—HTR2A—adrenal gland—hypertension	0.000194	0.00463	CbGeAlD
Minaprine—HTR2A—endocrine gland—hypertension	0.000168	0.00401	CbGeAlD
Minaprine—CYP2D6—endocrine gland—hypertension	0.000153	0.00366	CbGeAlD
Minaprine—HTR2A—central nervous system—hypertension	0.000151	0.00362	CbGeAlD
Minaprine—CYP2D6—central nervous system—hypertension	0.000138	0.00329	CbGeAlD
Minaprine—Gefitinib—ALB—hypertension	0.000112	0.117	CrCbGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—hypertension	2.35e-06	1.77e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3R1—hypertension	2.34e-06	1.77e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NOS3—hypertension	2.34e-06	1.77e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—C3—hypertension	2.34e-06	1.76e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOTCH1—hypertension	2.33e-06	1.75e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PDGFB—hypertension	2.33e-06	1.75e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGFR1—hypertension	2.32e-06	1.75e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SERPINE1—hypertension	2.32e-06	1.74e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PDGFB—hypertension	2.29e-06	1.73e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GOT1—hypertension	2.29e-06	1.72e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HIF1A—hypertension	2.28e-06	1.72e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGFR1—hypertension	2.28e-06	1.72e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PDGFB—hypertension	2.28e-06	1.72e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AGT—hypertension	2.27e-06	1.71e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGFR1—hypertension	2.27e-06	1.71e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTEN—hypertension	2.26e-06	1.71e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HIF1A—hypertension	2.25e-06	1.69e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FGF2—hypertension	2.24e-06	1.69e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AGT—hypertension	2.24e-06	1.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CALM1—hypertension	2.24e-06	1.68e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RHOA—hypertension	2.23e-06	1.68e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HIF1A—hypertension	2.23e-06	1.68e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—LEP—hypertension	2.23e-06	1.68e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—hypertension	2.23e-06	1.68e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AGT—hypertension	2.23e-06	1.68e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—STK11—hypertension	2.22e-06	1.67e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP19A1—hypertension	2.22e-06	1.67e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3R1—hypertension	2.21e-06	1.67e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NOS3—hypertension	2.21e-06	1.67e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CAV1—hypertension	2.21e-06	1.66e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—RELA—hypertension	2.21e-06	1.66e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOA1—hypertension	2.2e-06	1.66e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CALM1—hypertension	2.2e-06	1.66e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—LEP—hypertension	2.19e-06	1.65e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—hypertension	2.19e-06	1.65e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CALM1—hypertension	2.19e-06	1.65e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KDR—hypertension	2.18e-06	1.64e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—LEP—hypertension	2.18e-06	1.64e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—hypertension	2.18e-06	1.64e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CAV1—hypertension	2.17e-06	1.64e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—POMC—hypertension	2.17e-06	1.63e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOA1—hypertension	2.17e-06	1.63e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MTOR—hypertension	2.16e-06	1.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CAV1—hypertension	2.16e-06	1.63e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—EP300—hypertension	2.16e-06	1.63e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—INS—hypertension	2.16e-06	1.62e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOA1—hypertension	2.16e-06	1.62e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KDR—hypertension	2.15e-06	1.62e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KDR—hypertension	2.14e-06	1.61e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTEN—hypertension	2.13e-06	1.61e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL2—hypertension	2.12e-06	1.6e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FN1—hypertension	2.1e-06	1.58e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PRKCB—hypertension	2.1e-06	1.58e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—F2—hypertension	2.1e-06	1.58e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1—hypertension	2.09e-06	1.57e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT2—hypertension	2.08e-06	1.57e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RELA—hypertension	2.08e-06	1.57e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCL8—hypertension	2.08e-06	1.57e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EGFR—hypertension	2.08e-06	1.56e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FN1—hypertension	2.07e-06	1.56e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—F2—hypertension	2.07e-06	1.56e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PRKCB—hypertension	2.07e-06	1.56e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—COMT—hypertension	2.07e-06	1.56e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PRKCB—hypertension	2.06e-06	1.55e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—F2—hypertension	2.06e-06	1.55e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FN1—hypertension	2.06e-06	1.55e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH1—hypertension	2.06e-06	1.55e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MTOR—hypertension	2.04e-06	1.54e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARGC1A—hypertension	2.04e-06	1.53e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GNB3—hypertension	2.04e-06	1.53e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—EP300—hypertension	2.03e-06	1.53e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HMOX1—hypertension	2.03e-06	1.53e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH1—hypertension	2.02e-06	1.52e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH1—hypertension	2.01e-06	1.52e-05	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—hypertension	2.01e-06	1.51e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAT—hypertension	2e-06	1.51e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GNAS—hypertension	1.98e-06	1.49e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SERPINE1—hypertension	1.98e-06	1.49e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—hypertension	1.98e-06	1.49e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—hypertension	1.96e-06	1.48e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOB—hypertension	1.94e-06	1.46e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGF2—hypertension	1.92e-06	1.44e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—POMC—hypertension	1.91e-06	1.44e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RHOA—hypertension	1.91e-06	1.44e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—INS—hypertension	1.9e-06	1.43e-05	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—hypertension	1.89e-06	1.43e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3R1—hypertension	1.89e-06	1.42e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOS3—hypertension	1.89e-06	1.42e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTM1—hypertension	1.89e-06	1.42e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—POMC—hypertension	1.88e-06	1.42e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—hypertension	1.88e-06	1.42e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CDKN1A—hypertension	1.87e-06	1.41e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—POMC—hypertension	1.87e-06	1.41e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—INS—hypertension	1.87e-06	1.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL2—hypertension	1.87e-06	1.41e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—hypertension	1.87e-06	1.41e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—hypertension	1.86e-06	1.4e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—INS—hypertension	1.86e-06	1.4e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—LPL—hypertension	1.85e-06	1.4e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL2—hypertension	1.84e-06	1.39e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—hypertension	1.84e-06	1.39e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT2—hypertension	1.84e-06	1.39e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL2—hypertension	1.83e-06	1.38e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—hypertension	1.83e-06	1.38e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK8—hypertension	1.83e-06	1.38e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—hypertension	1.82e-06	1.37e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ADCY5—hypertension	1.82e-06	1.37e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—hypertension	1.81e-06	1.36e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT2—hypertension	1.81e-06	1.36e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GPX1—hypertension	1.81e-06	1.36e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—hypertension	1.8e-06	1.36e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—hypertension	1.8e-06	1.36e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT2—hypertension	1.8e-06	1.36e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—hypertension	1.79e-06	1.35e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PRKCA—hypertension	1.79e-06	1.35e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP1A1—hypertension	1.79e-06	1.35e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EP300—hypertension	1.78e-06	1.34e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RELA—hypertension	1.78e-06	1.34e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—hypertension	1.77e-06	1.34e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CDKN1A—hypertension	1.77e-06	1.33e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—hypertension	1.76e-06	1.33e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CD36—hypertension	1.76e-06	1.33e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SERPINE1—hypertension	1.75e-06	1.32e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MTOR—hypertension	1.75e-06	1.31e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SRC—hypertension	1.73e-06	1.31e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK8—hypertension	1.72e-06	1.3e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—hypertension	1.72e-06	1.3e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SERPINE1—hypertension	1.72e-06	1.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SERPINE1—hypertension	1.71e-06	1.29e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGF2—hypertension	1.69e-06	1.27e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—hypertension	1.69e-06	1.27e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RHOA—hypertension	1.69e-06	1.27e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EP300—hypertension	1.68e-06	1.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—hypertension	1.68e-06	1.26e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MTHFR—hypertension	1.67e-06	1.26e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOS3—hypertension	1.67e-06	1.26e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3R1—hypertension	1.67e-06	1.26e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGF2—hypertension	1.67e-06	1.25e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RHOA—hypertension	1.66e-06	1.25e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGF2—hypertension	1.66e-06	1.25e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RHOA—hypertension	1.65e-06	1.24e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3R1—hypertension	1.64e-06	1.24e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOS3—hypertension	1.64e-06	1.24e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARA—hypertension	1.64e-06	1.23e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SRC—hypertension	1.64e-06	1.23e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOS3—hypertension	1.63e-06	1.23e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3R1—hypertension	1.63e-06	1.23e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—hypertension	1.62e-06	1.22e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—hypertension	1.6e-06	1.2e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—hypertension	1.59e-06	1.2e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AGT—hypertension	1.59e-06	1.19e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RELA—hypertension	1.57e-06	1.18e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CALM1—hypertension	1.56e-06	1.17e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—hypertension	1.55e-06	1.17e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MYC—hypertension	1.55e-06	1.17e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TGFB1—hypertension	1.55e-06	1.17e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RELA—hypertension	1.55e-06	1.16e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MTOR—hypertension	1.54e-06	1.16e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAV1—hypertension	1.54e-06	1.16e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RELA—hypertension	1.54e-06	1.16e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOA1—hypertension	1.54e-06	1.16e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—hypertension	1.52e-06	1.14e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—hypertension	1.52e-06	1.14e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MTOR—hypertension	1.52e-06	1.14e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CDKN1A—hypertension	1.51e-06	1.14e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—hypertension	1.51e-06	1.14e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MTOR—hypertension	1.51e-06	1.14e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—hypertension	1.48e-06	1.12e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK8—hypertension	1.48e-06	1.11e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—hypertension	1.47e-06	1.11e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MYC—hypertension	1.47e-06	1.1e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TGFB1—hypertension	1.46e-06	1.1e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—hypertension	1.46e-06	1.1e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—hypertension	1.45e-06	1.09e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EP300—hypertension	1.44e-06	1.08e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—hypertension	1.43e-06	1.08e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—hypertension	1.43e-06	1.08e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—hypertension	1.41e-06	1.06e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—hypertension	1.41e-06	1.06e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—hypertension	1.4e-06	1.05e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SRC—hypertension	1.4e-06	1.05e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—hypertension	1.39e-06	1.04e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—hypertension	1.38e-06	1.04e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—hypertension	1.36e-06	1.03e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—hypertension	1.35e-06	1.02e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—hypertension	1.34e-06	1.01e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—POMC—hypertension	1.34e-06	1.01e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CDKN1A—hypertension	1.33e-06	1.01e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—hypertension	1.33e-06	1e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—INS—hypertension	1.33e-06	1e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—hypertension	1.32e-06	9.92e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CDKN1A—hypertension	1.31e-06	9.89e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—hypertension	1.31e-06	9.87e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—hypertension	1.31e-06	9.87e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CDKN1A—hypertension	1.31e-06	9.84e-06	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—hypertension	1.3e-06	9.83e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—hypertension	1.3e-06	9.81e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK8—hypertension	1.3e-06	9.81e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—hypertension	1.3e-06	9.78e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK8—hypertension	1.28e-06	9.65e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—hypertension	1.28e-06	9.63e-06	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—hypertension	1.28e-06	9.61e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK8—hypertension	1.27e-06	9.6e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—hypertension	1.27e-06	9.57e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EP300—hypertension	1.27e-06	9.56e-06	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MYC—hypertension	1.25e-06	9.44e-06	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TGFB1—hypertension	1.25e-06	9.42e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EP300—hypertension	1.25e-06	9.41e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EP300—hypertension	1.24e-06	9.36e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SRC—hypertension	1.23e-06	9.3e-06	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—hypertension	1.23e-06	9.26e-06	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—hypertension	1.23e-06	9.24e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ALB—hypertension	1.22e-06	9.17e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SRC—hypertension	1.21e-06	9.15e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SRC—hypertension	1.21e-06	9.1e-06	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—hypertension	1.2e-06	9.06e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—hypertension	1.2e-06	9.06e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—hypertension	1.18e-06	8.91e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—hypertension	1.18e-06	8.86e-06	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—hypertension	1.17e-06	8.8e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NOS3—hypertension	1.16e-06	8.77e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3R1—hypertension	1.16e-06	8.77e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MYC—hypertension	1.11e-06	8.33e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TGFB1—hypertension	1.1e-06	8.31e-06	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—hypertension	1.1e-06	8.3e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MYC—hypertension	1.09e-06	8.2e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TGFB1—hypertension	1.09e-06	8.18e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MYC—hypertension	1.08e-06	8.16e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—hypertension	1.08e-06	8.15e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TGFB1—hypertension	1.08e-06	8.14e-06	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—hypertension	1.08e-06	8.12e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—hypertension	1.06e-06	8.02e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—hypertension	1.06e-06	8.02e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—hypertension	1.06e-06	7.98e-06	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—hypertension	1.03e-06	7.75e-06	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—hypertension	1.02e-06	7.65e-06	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—hypertension	9.42e-07	7.1e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—hypertension	9.29e-07	7e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—hypertension	9.09e-07	6.84e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—hypertension	8.94e-07	6.73e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—hypertension	8.89e-07	6.7e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—EP300—hypertension	8.86e-07	6.67e-06	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—hypertension	8.69e-07	6.55e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—hypertension	8.32e-07	6.26e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—hypertension	8.18e-07	6.16e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—hypertension	8.14e-07	6.13e-06	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—hypertension	7.67e-07	5.78e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—hypertension	7.55e-07	5.69e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—hypertension	7.51e-07	5.66e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—hypertension	5.35e-07	4.03e-06	CbGpPWpGaD
